Microbiology & Infectious Diseases

The RSVpreF vaccine provides robust protection for older adults against RSV-related hospitalisations and emergency department visits.

A study from Mayo Clinic demonstrated the benefits of refining stool testing practices to improve antimicrobial stewardship for Clostridioides difficile.

A Phase 3 trial highlights the potential of twice-yearly subcutaneous lenacapavir as an effective PrEP option for diverse populations at risk of HIV infection.

A new study highlights the enduring effects of post-COVID-19 condition on children and young people.

A single amino acid change in the hemagglutinin protein of the H5N1 strain can enable the virus to target human-type glycan receptors.

A recent clinical trial explored the safety, immune response, and protective efficacy of a second-generation genetically modified Plasmodium falciparum malaria parasite.

Health authorities have identified new cases of Trichophyton mentagrophytes genotype VII, an emerging dermatophyte fungus, in New York City, USA.

Rapid malaria diagnostic tests significantly improved the management of febrile illness and modestly improved survival rates for children under 5.